← 返回

免疫细胞在肝脏肿瘤微环境中的作用:肠道微生物群衍生因子的参与

英文原题:The role of immune cells in the liver tumor microenvironment: an involvement of gut microbiota-derived factors.

查看英文原题

The role of immune cells in the liver tumor microenvironment: an involvement of gut microbiota-derived factors.

PubMed 2022/09/06(内容时间) Int Immunol Q3 · IF 3.4(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

人类肠道中栖息着500多种微生物群,与宿主人类共存。肠道微生物代谢产物和组分从肠道吸收后,影响肝脏中的细胞,包括肝细胞和基质细胞,如肝窦内皮细胞、肝星状细胞、Kupffer细胞、自然杀伤(NK)细胞、NK T细胞及其他免疫细胞。这一从肠道到肝脏的轴被称为“肠-肝轴”,凸显了肠道与肝脏之间联系的重要性。在本综述中,我们讨论影响肝脏细胞的肠道微生物组分和代谢产物,特别是与免疫细胞相关的部分,以及相关的反应。我们还重点阐述肠道微生物群介导肝癌发生的机制,并讨论癌症预防,包括近期阐明的肠道微生物群对免疫检查点抑制剂疗效的调节作用。

展开英文摘要原文

More than 500 species of microbiota reside in the human intestine and coexist with humans, their host. Gut microbial metabolites and components are absorbed from the intestine and influence cells in the liver, including hepatocytes and stromal cells, such as liver sinusoidal endothelial cells, hepatic stellate cells, Kupffer cells, natural killer (NK) cells, NK T cells and other immune cells.

This gut-originated axis to the liver is called the "gut-liver axis", which underscores the importance of the link between the gut and the liver. In this review, we discuss the gut microbial components and metabolites that affect cells in the liver, particularly in association with immune cells, and the related responses.

We also highlight the mechanisms underlying gut microbiota-mediated liver carcinogenesis and discuss cancer prevention, including the recently clarified modulation of immune checkpoint inhibitor efficacy by the gut microbiota.

论文信息

作者
Kamiya T、Ohtani N
单位
Department of Pathophysiology, Graduate School of Medicine, Osaka Metropolitan University, 1-4-3 Asahi-machi, Abeno-ku, Osaka, Japan.Japan
文献类型
综述 · 非美国政府资助研究
期刊
International immunology2022 Sep 6
原文标识
PubMed 35652367 · DOI 10.1093/intimm/dxac020